Controversy Continues Over Muscular Dystrophy Drug, Despite FDA Approval
 

The Food and Drug Administration approved a muscular dystrophy drug despite deeply flawed evidence. Was the decision a dangerous precedent or flexible pragmatism reflecting patients' values?

أكثر...